Longitudinal assessment of lung function in Swiss childhood cancer survivors
Kasteler, R.; Otth, M.; Halbeisen, F. S.; Mader, L.; Singer, F.; Roessler, J.; von der Weid, N. X.; Ansari, M.; Kuehni, C. E.
Show abstract
RationaleChildhood cancer survivors (CCSs) are at increased risk for pulmonary morbidity due to exposure to lung-toxic treatments, including specific chemotherapies, radiotherapy, and surgery. Longitudinal data on lung function, with information on how outcomes change over time, in CCSs are scarce. ObjectivesTo investigate lung function trajectories in childhood cancer survivors over time and investigate the association with lung-toxic treatment. MethodsThis retrospective, multi-center cohort study included CCSs, who were diagnosed between 1990 and 2013 in Switzerland and had been exposed to lung-toxic chemotherapeutics or thoracic radiotherapy. Pulmonary function tests (PFTs) were obtained from hospital charts. We assessed quality of PFTs systematically and calculated z-scores and percentage predicted of forced expiratory volume in first second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, total lung capacity (TLC) and diffusion capacity for carbon-monoxide (DLCO) based on recommended reference equations. We described lung function over time and determined risk factors for change in FEV1 and FVC using multivariable linear regression. ResultsWe included 790 PFTs from 183 CCSs, with a median age of 12 years (IQR 7 - 14) at diagnosis. Common diagnoses were lymphoma (55%), leukemia (11%) and CNS tumors (12%). Median follow-up time was 5.5 years. Half (49%) of CCSs had at least one abnormal pulmonary function parameter, with restrictive impairment being common (22%). Trajectories of FEV1 and FVC started at z-scores of -1.5 at diagnosis and remained low throughout follow-up. CCSs treated with thoracic surgery started particularly low, with an FEV1 of -1.08 z-scores (-2.02 to -0.15) and an FVC of -1.42 z-scores (-2.27 to -0.57) compared to those without surgery. In CCS exposed to lung-toxic chemotherapeutics FEV1 z-scores increased slightly over time (0.12 per year; 95%CI 0.02 - 0.21). ConclusionThe large proportion of CCSs with reduced lung function identified in this study underlines the need for more research and long-term surveillance of this vulnerable population.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Safety and effectiveness of RBD-specific polyclonal equine F(ab′)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: a retrospective cohort study 90%
- Southern European Prospective Investigation Into Childhood Cancer and Nutrition (EPIC kids ): Study Design and Protocol 90%
- Childhood Cancer Survival in the Highly Vulnerable Population of South Texas: A Cohort Study 89%
Similar papers in this journal
- Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: A multicountry cohort study 88%
- Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern 88%
- The Association of Alpha Globin Gene Copy Number with Exhaled Nitric Oxide in a Cross-sectional Study of Healthy Black Adults 88%
Similar papers in this journal
Similar papers in this journal
- Income inequality and access to advanced immunotherapy for lung cancer: the case of Durvalumab in the Netherlands 91%
- Performance of ICD-10-based injury severity scores in pediatric trauma patients using the ICD-AIS map and survival rate ratios 86%
- Information bias of vaccine effectiveness estimation due to informed consent for national registration of COVID-19 vaccination: estimation and correction using a data augmentation model 86%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.